Valuation: BioGaia AB

Market Cap 12.71B 1.25B 1.14B 1.05B 949M 1.79B 117B 1.86B 5.02B 62.93B 4.68B 4.58B 199B P/E 2026 *
31.4x
P/E 2027 * 25.9x
Enterprise Value 12.03B 1.18B 1.08B 996M 899M 1.69B 110B 1.76B 4.76B 59.59B 4.43B 4.34B 188B EV / Sales 2026 *
7.13x
EV / Sales 2027 * 6.25x
Free-Float
80.82%
Yield 2026 *
2.71%
Yield 2027 * 2.96%
1 day+0.48%
1 week-0.32%
Current month+3.99%
1 month+0.64%
3 months+8.87%
6 months-5.30%
Current year+17.89%
1 week 125
Extreme 125
128.2
1 month 117.5
Extreme 117.5
135
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 54
Extreme 54
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Director/Board Member 46 01/01/2015
Director/Board Member 40 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/10/26 Sell

Director

-20,000 0.0203%
26/10/26 Sell

Director

-10,000 0.0102%
26/10/26 Sell

Director

-10,000 0.0102%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-0.32%+24.58%+22.03% 1.25B
-2.32%-3.79%+34.24%+133.69% 1,232B
-2.15%-2.75%+36.35%+82.05% 656B
-2.33%-3.04%+22.29%+106.80% 506B
-0.41%-1.03%+29.69%+69.64% 382B
-3.90%-6.39%+42.88%+35.41% 340B
-2.37%-4.38%+25.55%+52.28% 294B
-0.74%-2.73%-0.34%+34.08% 278B
-3.07%-5.17%+29.04%+67.26% 240B
-0.75%-0.44%+32.87%+123.96% 210B
Average -1.76%-2.09%+27.72%+72.72% 414B
Weighted average by Cap. -2.11%-2.67%+30.09%+91.37%

Financials

2026 *2027 *
Net sales 1.69B 166M 151M 140M 126M 237M 15.48B 247M 667M 8.36B 622M 609M 26.39B 1.92B 188M 172M 159M 143M 270M 17.61B 281M 759M 9.51B 707M 692M 30.02B
Net income 408M 40.11M 36.58M 33.82M 30.52M 57.48M 3.75B 59.75M 161M 2.02B 150M 147M 6.39B 490M 48.09M 43.86M 40.55M 36.59M 68.92M 4.49B 71.64M 194M 2.43B 180M 177M 7.66B
Net Debt -675M -66.24M -60.41M -55.86M -50.41M -94.94M -6.19B -98.68M -267M -3.34B -249M -243M -10.55B -716M -70.26M -64.08M -59.25M -53.47M -101M -6.57B -105M -283M -3.54B -264M -258M -11.19B
Projected Income Statement - Annual - BioGaia AB
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
19/11/26 SEK 125.20 -0.32% 2,520
18/11/26 SEK 125.60 +0.24% 83,221
17/11/26 SEK 125.30 -0.87% 95,673
16/11/26 SEK 126.40 +0.08% 99,520
13/11/26 SEK 126.30 +0.56% 74,722
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - BioGaia AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
125.60SEK
Average target price
152.00SEK
Spread / Average Target
+21.02%
  1. Stock Market
  2. Stocks
  3. BIOG B Stock